Lexicon Pharmaceuticals
LXRX
#6409
Rank
S$1.07 B
Marketcap
S$2.42
Share price
-1.57%
Change (1 day)
150.97%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): S-$0.26

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$0.24. In 2024 the company made an earnings per share (EPS) of S-$0.82 an increase over its 2023 EPS that were of S-$1.03.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.26-69.01%
2024S-$0.82-20%
2023S-$1.0331.15%
2022S-$0.79-0%
2021S-$0.7910.91%
2020S-$0.71-145.08%
2019S$1.57-206.09%
2018S-$1.48-5.74%
2017S-$1.57-10.95%
2016S-$1.762640%
2015S-$0.06436-96.34%
2014S-$1.76-2.53%
2013S-$1.80-9.09%
2012S-$1.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
S$23.45-9,689.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$7.12-3,010.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$54.74-22,484.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S-$7.86 3,115.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$8.11-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S-$0.64 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S-$0.97 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$1.80-836.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S-$98.74 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA